Literature DB >> 2543458

Polydispersity of aggregates formed by the polyene antibiotic amphotericin B and deoxycholate. A spin label study.

M T Lamy-Freund1, V F Ferreira, S Schreier.   

Abstract

The amphotericin B-deoxycholate (AB-DOC) system (1:2, mole basis) was studied with regard to its organizational properties making use of spin label ESR spectra. The spectra of a fatty acid spin label intercalated in AB-DOC preparations revealed two components, one strongly (S) and one weakly (W) immobilized. Spectral subtractions indicated that S corresponds to label in mixed AB-DOC aggregates while W is due to label in deoxycholate micelles. This situation, coexistence of different aggregates, is similar to that found in systems consisting of bile salts and phospholipids. The DOC/AB mole ratio in the mixed aggregate is highest when pure DOC micelles are present. Dilution leads to disappearance of the latter and to continuous loss of DOC from AB-DOC accompanied by an increase in size and decrease in solubility of the aggregates, as verified by filtration and centrifugation experiments. The results indicate that AB-DOC systems are polydisperse. Since amphotericin B preparations having different organizational properties display different toxic and therapeutic effect, the study of amphotericin B aggregates should help in understanding these phenomena at a molecular level.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2543458     DOI: 10.1016/0005-2736(89)90030-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index.

Authors:  F Gaboriau; M Chéron; C Petit; J Bolard
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

Review 2.  Structural insights on biologically relevant cationic membranes by ESR spectroscopy.

Authors:  Julio H K Rozenfeld; Evandro L Duarte; Tiago R Oliveira; M Teresa Lamy
Journal:  Biophys Rev       Date:  2017-08-23

3.  Activity and kinetics of dissociation and transfer of amphotericin B from a novel delivery form.

Authors:  B Baas; K Kindt; A Scott; J Scott; P Mikulecky; S C Hartsel
Journal:  AAPS PharmSci       Date:  1999

4.  Structure-activity study of inhibition of amphotericin B (Fungizone) binding to sterols, toxicity to cells, and lethality to mice by esters of sucrose.

Authors:  I Gruda; D Milette; M Brother; G S Kobayashi; G Medoff; J Brajtburg
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

5.  Amphotericin B incorporated into egg lecithin-bile salt mixed micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycoses.

Authors:  J Brajtburg; S Elberg; G S Kobayashi; J Bolard
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

6.  Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes.

Authors:  P Legrand; E A Romero; B E Cohen; J Bolard
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

Review 7.  Nanopharmaceuticals (part 1): products on the market.

Authors:  Volkmar Weissig; Tracy K Pettinger; Nicole Murdock
Journal:  Int J Nanomedicine       Date:  2014-09-15

8.  Amphotericin B release rate is the link between drug status in the liposomal bilayer and toxicity.

Authors:  Yuri Svirkin; Jaeweon Lee; Richard Marx; Seongkyu Yoon; Nelson Landrau; Md Abul Kaisar; Bin Qin; Jin H Park; Khondoker Alam; Darby Kozak; Yan Wang; Xiaoming Xu; Jiwen Zheng; Benjamin Rivnay
Journal:  Asian J Pharm Sci       Date:  2022-06-08       Impact factor: 9.273

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.